← Back to headlines
Erasca Shares Jump on Partnership with Merck for Drug Trial
Erasca announced a collaboration with Merck to test its drug ERAS-0015 in combination with Keytruda, causing a significant increase in Erasca's share price.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
